AORTIC VALVE SCLEROSIS: PHYSIOLOGICAL STUDY OF HEART VALVES

Authors

  • Qasim Hamadi Abid Pathological analysis department, College of applied medical science, university of Karbala, 1 Karbala, Iraq
  • Noor H. Alkharsan Pathological analysis department, College of applied medical science, university of Karbala, 2 Karbala, Iraq
  • Huda Najh Al Baroody Pathological analysis department, College of applied medical science, university of Karbala, 3 Karbala, Iraq

Keywords:

Aortic valve sclerosis, Atherosclerosis and Inflammation

Abstract

One important clinical condition that often presents asymptomatically in adult populations is aortic valve sclerosis (AVS). It negatively impacts the cardiovascular system as an early stage of aortic valve stenosis and a marker for cardiovascular disease.

References

-Owens, D.S. and Otto, C.M.(2009). Is it Time for a New Paradigm in Calcific Aortic Valve Disease? J. Am. Coll.

Cardiol. Img., 2;928-930.

-Vinodh Jeevanantham; Natasha, Singh; Kenneth Izuora and John P.(2007).Correlation of High Sensitivity

C-reactive protein and Calcific Aortic Valve Disease. Mayo Clin Proc 82 (2): 171-174.

-Sanchez P. L.and Mazzone ,A. M. 1: 2006; C-reactive protein in degenerative aortic valve stenosis. Cardiovascular

Ultrasound 4: 24.

-Freeman, R.V. and Otto, C.M. (2005).Spectrum of calcific aortic valve disease. Pathogenesis, disease progression

and treatment strategies. Circulation,111:3316-3326.

-Agmon, Y.; Khandheria, B.K. and TajiK, J.A. (2004). Inflammation, infection, and aortic valve sclerosis: Insights

from the Olmsted County (Minnesota) population. Atherosclerosis,174:337–342.

-Boon, A.; Cheriex, E.; Lodder, J. and Kessels, F. (1997).Cardiac valve calcification: characteristics of patients

with calcification of the mitral annulus or aortic valve. Heart, 78:472-474.

-Stewart, B.F.; Siscovick, D.; Lind, B.K. ;Gardin, J.M.;Gottdiener, J.S.; Smith, V.E..; Kitzman, D.W. and

Otto, C.M. (1997). Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll

Cardiol, 29:630-4.

-Goldbarg, S.H.; Elmariah ,S.; Miller, M.A. and Fuster, V. (2007).Insights Into Degenerative Aortic Valve

Disease. J Am Coll Cardiol,50:1205–13.

-Kibble, J.D. and Halsey C.R.(2009).The Big Picture.Medical Physiology. New York ;The McGraw-Hill.

-Mihaljevic, T. ; Sayeed, M.R. , Stamou, S.C. and Paul, S.(2008). Pathophysiology of Aortic Valve Disease

,Cohn Lh, ed. Cardiac Surgery in the Adult. New York: McGraw-Hill, 2008:825-840.

-Anderson, R.H.; Devine, W.A.; Ho, S.Y.; Smith, A. and McKay, R. (1991). The myth of the aortic annulus:

The anatomy of the subaortic outflow tract. Ann Thorac Surg 52:640.

-Freeman, R.V. and Otto, C.M. (2005).Spectrum of calcific aortic valve disease. Pathogenesis, disease

progression and treatment strategies. Circulation,111:3316-3326.

-Rajamannan, N.M and Otto, C.M. (2004).Targeted therapy to prevent progression of calcific aortic stenosis.

Circulation 110:1180—2.

-Rashidi, A.; Adler, D.S.; Casscells, W. and Madjid, M. (2005). Is it time to prescribe statins to patients with

calcified aortic stenosis? Am Heart J 150:41-5.

-Baldassarre, D. ; De Jong, A.; Amato, M.; Werba, J.P.,; Castelnuovo, S.; Frigerio, B.; Veglia, F.; Tremoli,

E. and Sirtori, CR. (2008). Carotid intima-media thickness and markers of inflammation, endothelial damage and

hemostasis. Ann Med;40:21—44.

-Diehl, P. ; Nagy, F. ;Sossong ,V.; Helbing, T. ; Beyersdorf, F.; Olschewski, M.; Bode, C. and Moser, M.

(2008).Increased levels of circulating microparticles in patients with severe aortic valve stenosis. Thromb Haemost

:711-9.

-Parolari,A.; Loardi, C.; Mussoni,L. ; Cavallotti, L.; Marina,C.; Biglioli, P.; Tremoli ,E. and Alamanni F.

(2009). Nonrheumatic calcific aortic stenosis: an overview from basic science to pharmacological prevention. Eur J

Cardiothorac Surg. 35:493 -504.

-Ngo, D.T.; Pharm, B. ;Sverdlov, A.L.; Willoughby, S.R.;Nightingale, A.K.; Chirkov, Y.Y.; McNeil, J. and

Horowitz J.D.(2009). Determinants of Occurrence of Aortic Sclerosis in an Aging Population J Am Coll Cardiol Img,

:919-927.

-Otto, C.M. ;Kuusisto, J.; Reichenbach, D.D. (1994): Characterization of the early lesion of

‘degenerative’valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 90:844–853.

-O’Brien, K.D.; Shavelle, D.M.; Caulfield, M.T.; McDonald, T.O.; Olin-Lewis, K.; Otto, C.M. and

Probstfield, J.L. (2002).Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular

lesions and in human plasma. Circulation 106:2224-30.

-Caira, F.C.; Stock, S.R.; Gleason, T.G.; McGee ,E.C. Huang, J. Bonow, R.O.; Spelsberg, T.C.; McCarthy,

PM. ;Rahimtoola, SH. and Rajamannan NM. (2006).Human degenerative valve disease is associated with upregulation of lowdensity lipoprotein receptor-related protein 5 receptor-mediated bone formation. J Am Coll Cardiol

:1707-12.

Downloads

Published

2024-09-21

How to Cite

Qasim Hamadi Abid, Noor H. Alkharsan, & Huda Najh Al Baroody. (2024). AORTIC VALVE SCLEROSIS: PHYSIOLOGICAL STUDY OF HEART VALVES. European Journal of Humanities and Educational Advancements, 5(9), 40-44. Retrieved from https://scholarzest.com/index.php/ejhea/article/view/4728

Issue

Vol. 5 No. 9 (2024): EJHEA

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.